Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Mortality in patients with dementia treated with atypical antipsychotics (olanzapine, quetiapine and ziprasidone).

Martínez Martínez L, Olivera Fernández MR, Piñeiro Corrales G.

Farm Hosp. 2009 Jul-Aug;33(4):224-8. English, Spanish.

PMID:
19712611
2.

Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.

Finkel S, Kozma C, Long S, Greenspan A, Mahmoud R, Baser O, Engelhart L.

Int Psychogeriatr. 2005 Dec;17(4):617-29. Epub 2005 Oct 5.

PMID:
16202186
4.

[Descriptive analysis of the use of atypical antipsychotics under compassionate-use in a health area in Ferrol (La Coruña, Spain)].

Santos-García D, Macías M, Casás-Martínez A, Llaneza M, Abella J, Aneiros A, Santos H, Domínguez-Urbistondo G, Salazar-Laya B.

Neurologia. 2010 Jun;25(5):300-8. Spanish.

5.

Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.

Maust DT, Kim HM, Seyfried LS, Chiang C, Kavanagh J, Schneider LS, Kales HC.

JAMA Psychiatry. 2015 May;72(5):438-45. doi: 10.1001/jamapsychiatry.2014.3018.

6.

Increase in mortality rate in patients with dementia treated with atypical antipsychotics: a cohort study in outpatients in Central Italy.

Piersanti M, Capannolo M, Turchetti M, Serroni N, De Berardis D, Evangelista P, Costantini P, Orsini A, Rossi A, Maggio R.

Riv Psichiatr. 2014 Jan-Feb;49(1):34-40. doi: 10.1708/1407.15623.

PMID:
24572582
7.

Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia?

Rossom RC, Rector TS, Lederle FA, Dysken MW.

J Am Geriatr Soc. 2010 Jun;58(6):1027-34. doi: 10.1111/j.1532-5415.2010.02873.x. Epub 2010 May 7.

PMID:
20487081
8.

Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: a 12-week open-label, multicentre clinical trial.

Lublin H, Haug HJ, Koponen H, Sigmundsson T, Kolb SA.

World J Biol Psychiatry. 2009;10(4 Pt 3):710-8. doi: 10.1080/15622970802269589.

PMID:
18803070
9.

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK; Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators.

N Engl J Med. 2005 Sep 22;353(12):1209-23. Epub 2005 Sep 19. Erratum in: N Engl J Med. 2010 Sep 9;363(11):1092-3.

10.

Optimizing atypical antipsychotic treatment strategies in the elderly.

Katz IR.

J Am Geriatr Soc. 2004 Dec;52(12 Suppl):S272-7. Review. No abstract available.

PMID:
15541168
11.

Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.

Jing Y, Kim E, You M, Pikalov A, Tran QV.

J Med Econ. 2009 Jun;12(2):104-13. doi: 10.3111/13696990903044092.

PMID:
19527195
12.

Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara.

Chiabrando G, Bianchi S, Poluzzi E, Montanaro N, Scanavacca P.

Eur J Clin Pharmacol. 2010 Jul;66(7):661-9. doi: 10.1007/s00228-010-0828-z. Epub 2010 May 13.

PMID:
20464383
13.

Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.

Østbye T, Curtis LH, Masselink LE, Hutchison S, Wright A, Dans PE, Schulman KA, Krishnan RR.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):407-15.

PMID:
15372671
14.

FDA warns antipsychotic drugs may be risky for elderly.

Kuehn BM.

JAMA. 2005 May 25;293(20):2462. No abstract available.

PMID:
15914734
15.

Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex.

Marras C, Herrmann N, Anderson GM, Fischer HD, Wang X, Rochon PA.

Am J Geriatr Pharmacother. 2012 Dec;10(6):381-9. doi: 10.1016/j.amjopharm.2012.11.001.

PMID:
23217531
16.
17.
18.

Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia.

Mullins CD, Obeidat NA, Cuffel BJ, Naradzay J, Loebel AD.

Schizophr Res. 2008 Jan;98(1-3):8-15. Epub 2007 Jun 26.

PMID:
17596914
19.

Risk of mortality among individual antipsychotics in patients with dementia.

Kales HC, Kim HM, Zivin K, Valenstein M, Seyfried LS, Chiang C, Cunningham F, Schneider LS, Blow FC.

Am J Psychiatry. 2012 Jan;169(1):71-9. doi: 10.1176/appi.ajp.2011.11030347. Epub 2011 Oct 31.

20.

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.

Correll CU, Leucht S, Kane JM.

Am J Psychiatry. 2004 Mar;161(3):414-25. Review.

PMID:
14992963

Supplemental Content

Support Center